Skip to content

KMTS KMTS Net Income

Net Income at other companies

Abbott logo
AbbottABT
$1.08B-18.7%
Boston Scientific logo
Boston ScientificBSX
$1.34B+99.3%
Medtronic logo
MedtronicMDT
$1.24B+17.8%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
-$13.93M+54.6%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$41M+36.0%
Haemonetics logo
HaemoneticsHAE
$44.74M+19.3%

Other financials

Income statement

See full
Revenue$24.6M+62.7%
Gross profit$12.9M+97.1%
Operating income-$34.8M-68.8%
EPS (diluted)-$0.61+51.2%

Balance sheet

See full
Cash & equivalents$291.3M+436%
Total debt$43.8M
Total assets$379.3M

Cash flow

See full
Operating cash flow-$18.4M-2.1%
CapEx$9.8M+141%
Free cash flow-$28.2M-27.7%

Valuation

See full
Market cap$1.29B
Enterprise value$1.04B
P/S15.4×

Profitability

See full
Gross margin48.8%+15.1pp
Operating margin-171.5%+12.9pp
Net margin-173%+0.8pp
FCF margin-142.9%-25.3pp

Returns & leverage

See full
Current ratio7.3×

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KMTS's net income?
KMTS (KMTS) reported net income of -$34.17M in Q4 2025.
How has KMTS's net income changed year-over-year?
KMTS's net income decreased by 58.8% year-over-year, from -$21.51M to -$34.17M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.